Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other ...

President Donald Trump is launching a new government-run website that he says will let Americans buy medications at lower prices. The new website, called TrumpRx, is expected to launch in 2026 and ...

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.

The Trump administration will hold off on imposing pharmaceutical tariffs Oct. 1 for companies that do not onshore manufacturing or participate in the president’s “Most Favored Nations” pricing ...

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Pfizer Inc. (NYSE:PFE) is one of the top performers on Tuesday. Pfizer Inc. extended its winning streak to a third straight ...

The Trump administration says it is making deals with drug companies to lower prices U.S. consumers pay for medicines. But key details are missing on how the initiative would work.

Pfizer only offered to discount six products through the Most Favored Nation program, and healthcare policy experts suggest the real-world impact remains uncertain.

Prescription drug prices in the US are roughly 2.78 times higher on average than in 33 other high-income countries, a 2024 report by the RAND Corporation found.

TrumpRx will connect people to companies' direct-to-consumer programs, but experts caution that many people are unlikely to save money from it.

Pfizer will charge most-favored-nation prices to Medicaid, matching the lowest prices in developed countries. Savings on primary care and specialty drugs are expected to range from 50 percent to 85 ...

Pfizer announced that it will join forces with President Trump to launch a new government direct-to-consumer drug sales website.

Amid a series of federal policy changes, President Donald Trump and Pfizer announced an agreement this week aimed at lowering prescription drug costs in the United States. Under the agreement, Pfizer ...